Douglas Bailey
Family Medicine · Junction City, ORNPI 1972669778
Payments from drug & device makers
Across 173 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$487
- Amgen$314
- Pfizer$307
- Novo Nordisk$278
- Johnson & Johnson$176
- Amarin Pharma, Inc.$134
- plus $877 from 15 others
What the payments were for
- Food & beverage$2,560100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $487 |
| Amgen | 16 | $314 |
| Pfizer | 20 | $307 |
| Novo Nordisk | 29 | $278 |
| Johnson & Johnson | 12 | $176 |
| Amarin Pharma, Inc. | 8 | $134 |
| AbbVie(2 entities) | 8 | $125 |
| Amneal Pharmaceuticals LLC | 5 | $112 |
| E.r. Squibb & Sons, L.L.C. | 20 | $110 |
| Lilly USA, LLC | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Astellas Pharma US Inc | 5 | $69 |
| Boehringer Ingelheim | 3 | $66 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| GSK | 2 | $29 |
| Antares Pharma, Inc. | 2 | $23 |
| Merck | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Strongbridge US Inc. | 1 | $16 |
How this compares
$2,572 in reported general payments places this provider in the 90th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,790 |
| Levothyroxine Sodium | 12 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $307 | $6,79011 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $112 | $15112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,221 family medicine providers in Oregon.
Other family medicine in Junction City
- John DelgadoAshland$4.3M
- John MickelsonLincoln City$2.1M
- Subramaniam SeetharamanMilwaukie$1.8M
- Eden MillerBend$1.7M
- Maureen MaysPortland$491K
- Thomas TurkRoseburg$434K
- Anil RajaniHood River$325K
- Patricia BuchananEugene$239K
- Keith KlattAstoria$166K
- Stephen NelsonMedford$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.